Reconstruction by Thoracodorsal Artery Perforator Flap in Patients With Upper Body Soft Tissue Defects

Reconstructive Potential of The Pedicled Thoracodorsal Artery Perforator Flap; Prospective Clinical Assessment of The Arc of Rotation and Recipient-Site Reach in Upper Body Reconstruction

Status

Enrolling by invitation

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07734337

Enrollment

Registered

2026-07-29

Start date

2025-03-03

Completion date

2027-04-03

Last updated

2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reconstruction of Upper Body Soft Tissue Defects

Keywords

TDAP flap recipient site reach

Brief summary

evaluation of versatility and reliability of thoracodorsal artery perforator flap by assessment of recipient site reach

Detailed description

Prospectively evaluate the reconstructive capacity of the pedicled thoracodorsal artery perforator (TDAP) flap by objectively measuring its arc of rotation and achievable recipient-site reach, and correlating these parameters with flap survival, complication rates, donor-site morbidity, and functional and aesthetic outcomes in upper body reconstruction.

Interventions

PROCEDUREReconstruction

Harvesting thoracodorsal artery perforator flap and insetting in the recipient sites reachable for this flap

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

Patients who need reconstruction in Arm, axilla, breast and chest

Eligibility

Sex/Gender

ALL

Age

5 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Patients aged 5 to 75 years old * Both sexes * Requiring upper body soft tissue reconstruction (e.g. breast, shoulder chest wall, axilla) following oncological resection, trauma, or contracture excision * Adequate general condition for surgery

Exclusion criteria

* Patients with uncontrolled comorbidities. * Prior surgery or radiation in the donor region that compromises vascular anatomy. * Active local infection or poor wound bed vascularity.

Design outcomes

Primary

Measure	Time frame	Description
Recipient Site Reach	12 months recruitment and 6 months follow up	Measuring of Successful reach to intended recipient site without vascular compromise by centimeters from the pedicle to the recipient site

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026